Increased expression of Mcl‐1 is responsible for the blockage of TRAIL‐induced apoptosis mediated by EGF/ErbB1 signaling pathway
- 1 July 2003
- journal article
- research article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 89 (6) , 1177-1192
Abstract
Epidermal growth factor (EGF) protects against death receptor induced apoptosis in epithelial cells. Herein, we demonstrate that EGF protection against tumor necrosis factor related apoptosis‐inducing ligand (TRAIL) induced apoptosis is mediated by increased expression of the Bcl‐2 family member myeloid cell leukemia 1 (Mcl‐1). EGF increased the mRNA and protein levels of Mcl‐1. Furthermore, expression of ErbB1 alone or in combination with ErbB2 in NIH3T3 cells up‐regulates Mcl‐1 following EGF treatment. In addition, up‐regulation of Mcl‐1 by EGF is mediated through AKT and NFκB activation since kinase inactive AKT and ΔIκB effectively blocks this up‐regulation. NFκB was also critical for the ability of EGF to prevent TRAIL induced apoptosis as a dominant negative IκB (ΔIκB) blocked NFκB activation, and relieved EGF protection against TRAIL mediated mitochondrial cytochrome‐c release and apoptosis. Finally, anti‐sense oligonucleotides directed against Mcl‐1 effectively reduced the protein levels of Mcl‐1 and blocked EGF protection against TRAIL induced mitochondrial cytochrome‐c release and apoptosis. Taken together, EGF signaling leads to increased Mcl‐1 expression that is required for blockage of TRAIL induced apoptosis.Keywords
This publication has 39 references indexed in Scilit:
- Antisense strategy shows that Mcl-1 rather than Bcl-2 or Bcl-xL is an essential survival protein of human myeloma cellsBlood, 2002
- TRAIL-induced apoptosis requires Bax-dependent mitochondrial release of Smac/DIABLOGenes & Development, 2002
- Identification of Inhibitors of TRAIL-induced Death (ITIDs) in the TRAIL-sensitive Colon Carcinoma Cell Line SW480 Using a Genetic ApproachJournal of Biological Chemistry, 2001
- Rb, mcl-1 and p53 expression correlate with clinical outcome in patients with liver metastases from colorectal cancerAnnals of Oncology, 2001
- Epidermal growth factor-induced nuclear factor κB activation: A major pathway of cell-cycle progression in estrogen-receptor negative breast cancer cellsProceedings of the National Academy of Sciences, 2000
- NF-κB activationCritical Care Medicine, 2000
- Cellular survival: a play in three AktsGenes & Development, 1999
- Mitochondria and cell deathEuropean Journal of Biochemistry, 1999
- Apoptosis control by death and decoy receptorsCurrent Opinion in Cell Biology, 1999
- EGF and Its Receptor: Historical PerspectiveJournal of Mammary Gland Biology and Neoplasia, 1997